Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Chemotherapy: A Senior Surgeon's Personal Challenge.

Gordon PH.

Dis Colon Rectum. 2018 Mar;61(3):275-278. doi: 10.1097/DCR.0000000000001040. No abstract available.

PMID:
29420421
2.

Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.

Blasco H, Patin F, Andres CR, Corcia P, Gordon PH.

Expert Opin Pharmacother. 2016 Aug;17(12):1669-82. doi: 10.1080/14656566.2016.1202919. Epub 2016 Jul 4. Review.

PMID:
27356036
3.

Further development of biomarkers in amyotrophic lateral sclerosis.

Blasco H, Vourc'h P, Pradat PF, Gordon PH, Andres CR, Corcia P.

Expert Rev Mol Diagn. 2016 Aug;16(8):853-68. doi: 10.1080/14737159.2016.1199277. Epub 2016 Jun 20. Review.

PMID:
27275785
4.

Huntington disease among the Navajo: A population-based study in the Navajo Nation.

Gordon PH, Mehal JM, Rowland AS, Cheek JE, Bartholomew ML.

Neurology. 2016 Apr 19;86(16):1552-3. doi: 10.1212/WNL.0000000000002486. Epub 2016 Feb 19. No abstract available.

5.

Metabolomics in amyotrophic lateral sclerosis: how far can it take us?

Blasco H, Patin F, Madji Hounoum B, Gordon PH, Vourc'h P, Andres CR, Corcia P.

Eur J Neurol. 2016 Mar;23(3):447-54. doi: 10.1111/ene.12956. Epub 2016 Jan 29. Review.

PMID:
26822316
6.
7.

Sigmoid Colectomy for Acute Diverticulitis in Immunosuppressed vs Immunocompetent Patients: Outcomes From the ACS-NSQIP Database.

Al-Khamis A, Abou Khalil J, Demian M, Morin N, Vasilevsky CA, Gordon PH, Boutros M.

Dis Colon Rectum. 2016 Feb;59(2):101-9. doi: 10.1097/DCR.0000000000000513.

PMID:
26734967
8.

A real-time spike classification method based on dynamic time warping for extracellular enteric neural recording with large waveform variability.

Cao Y, Rakhilin N, Gordon PH, Shen X, Kan EC.

J Neurosci Methods. 2016 Mar 1;261:97-109. doi: 10.1016/j.jneumeth.2015.12.006. Epub 2015 Dec 21.

9.

Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.

Veyrat-Durebex C, Corcia P, Piver E, Devos D, Dangoumau A, Gouel F, Vourc'h P, Emond P, Laumonnier F, Nadal-Desbarats L, Gordon PH, Andres CR, Blasco H.

Mol Neurobiol. 2016 Dec;53(10):6910-6924. Epub 2015 Dec 14.

PMID:
26666663
10.

Pure cerebellar ataxia linked to large C9orf72 repeat expansion.

Corcia P, Vourc'h P, Guennoc AM, Del Mar Amador M, Blasco H, Andres C, Couratier P, Gordon PH, Meininger V.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):301-3. doi: 10.3109/21678421.2015.1113298. Epub 2015 Nov 26. No abstract available.

PMID:
26609732
11.

Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression.

Blasco H, Nadal-Desbarats L, Pradat PF, Gordon PH, Madji Hounoum B, Patin F, Veyrat-Durebex C, Mavel S, Beltran S, Emond P, Andres CR, Corcia P.

Eur J Neurol. 2016 Feb;23(2):346-53. doi: 10.1111/ene.12851. Epub 2015 Oct 28.

PMID:
26508442
12.

Vitamin D is Not a Protective Factor in ALS.

Blasco H, Madji Hounoum B, Dufour-Rainfray D, Patin F, Maillot F, Beltran S, Gordon PH, Andres CR, Corcia P.

CNS Neurosci Ther. 2015 Aug;21(8):651-6. doi: 10.1111/cns.12423. Epub 2015 Jun 20.

13.

A common functional allele of the Nogo receptor gene, reticulon 4 receptor (RTN4R), is associated with sporadic amyotrophic lateral sclerosis in a French population.

Amy M, Staehlin O, René F, Blasco H, Marouillat S, Daoud H, Vourc'h P, Gordon PH, Camu W, Corcia P, Loeffler JP, Palkovits M, Sommer WH, Andres CR.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):490-6. doi: 10.3109/21678421.2015.1051988. Epub 2015 Jun 17.

PMID:
26083872
14.

Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.

Kleiman A, Al-Khamis A, Farsi A, Kezouh A, Vuong T, Gordon PH, Vasilevsky CA, Morin N, Faria J, Ghitulescu G, Boutros M.

J Gastrointest Surg. 2015 Jun;19(6):1106-12. doi: 10.1007/s11605-015-2814-3. Epub 2015 Apr 10.

PMID:
25859755
15.

Incidence and prevalence of Parkinson's disease among Navajo people living in the Navajo nation.

Gordon PH, Mehal JM, Holman RC, Bartholomew ML, Cheek JE, Rowland AS.

Mov Disord. 2015 Apr 15;30(5):714-20. doi: 10.1002/mds.26147. Epub 2015 Feb 4.

PMID:
25649219
16.

Is there a paraneoplastic ALS?

Corcia P, Gordon PH, Camdessanche JP.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):252-7. doi: 10.3109/21678421.2014.965178. Epub 2014 Oct 6. Review.

PMID:
25285651
17.

The glutamate hypothesis in ALS: pathophysiology and drug development.

Blasco H, Mavel S, Corcia P, Gordon PH.

Curr Med Chem. 2014;21(31):3551-75. Review.

PMID:
25245510
18.

Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago?

Cahill C, Gordon PH, Petrucci A, Boutros M.

World J Gastroenterol. 2014 Sep 7;20(33):11486-95. doi: 10.3748/wjg.v20.i33.11486. Review.

19.

Brait-Fahn-Schwarz disease: the missing link between ALS and Parkinson's disease.

Belin J, Gordon PH, Guennoc AM, De Toffol B, Corcia P.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):135-6. doi: 10.3109/21678421.2014.948880. Epub 2014 Aug 15. No abstract available.

PMID:
25125199
20.

Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease.

Blasco H, Nadal-Desbarats L, Pradat PF, Gordon PH, Antar C, Veyrat-Durebex C, Moreau C, Devos D, Mavel S, Emond P, Andres CR, Corcia P.

Neurology. 2014 Apr 1;82(13):1167-74. doi: 10.1212/WNL.0000000000000274. Epub 2014 Feb 28.

PMID:
24587475
21.

Encephalitis-associated hospitalizations among American Indians and Alaska Natives.

Mehal JM, Holman RC, Vora NM, Blanton J, Gordon PH, Cheek JE.

Am J Trop Med Hyg. 2014 Apr;90(4):755-9. doi: 10.4269/ajtmh.13-0420. Epub 2014 Feb 10.

22.

Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families.

Grunbaum A, Holcroft C, Heilpern D, Gladman S, Burstein B, Menard M, Al-Abbad J, Cassoff J, MacNamara E, Gordon PH, Szilagyi A.

Nutr J. 2013 Nov 9;12(1):145. doi: 10.1186/1475-2891-12-145.

23.

Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Veyrat-Durebex C, Corcia P, Dangoumau A, Laumonnier F, Piver E, Gordon PH, Andres CR, Vourc'h P, Blasco H.

Mol Neurobiol. 2014 Apr;49(2):966-83. doi: 10.1007/s12035-013-8573-9. Epub 2013 Nov 7. Review.

PMID:
24198229
24.
25.

The murky path to drug discovery in ALS becomes clearer.

Gordon PH.

Lancet Neurol. 2013 Nov;12(11):1037-8. doi: 10.1016/S1474-4422(13)70224-2. Epub 2013 Sep 23. No abstract available. Erratum in: Lancet Neurol. 2013 Dec;12(12):1133.

PMID:
24067399
26.

Programmable ion-sensitive transistor interfaces. II. Biomolecular sensing and manipulation.

Jayant K, Auluck K, Funke M, Anwar S, Phelps JB, Gordon PH, Rajwade SR, Kan EC.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jul;88(1):012802. Epub 2013 Jul 1.

PMID:
23944513
27.

Programmable ion-sensitive transistor interfaces. I. Electrochemical gating.

Jayant K, Auluck K, Funke M, Anwar S, Phelps JB, Gordon PH, Rajwade SR, Kan EC.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jul;88(1):012801. Epub 2013 Jul 1.

PMID:
23944512
28.

Prevalence of Parkinson disease among the Navajo: a preliminary examination.

Gordon PH, Zhao H, Bartley D, Sims LJ, Begay MG, Pirio Richardson S, Lewis J, Rowland AS.

J Parkinsons Dis. 2013;3(2):193-8. doi: 10.3233/JPD-120158.

29.

Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.

Blasco H, Corcia P, Pradat PF, Bocca C, Gordon PH, Veyrat-Durebex C, Mavel S, Nadal-Desbarats L, Moreau C, Devos D, Andres CR, Emond P.

J Proteome Res. 2013 Aug 2;12(8):3746-54. doi: 10.1021/pr400376e. Epub 2013 Jul 16.

PMID:
23859630
30.

A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS.

Blasco H, Bernard-Marissal N, Vourc'h P, Guettard YO, Sunyach C, Augereau O, Khederchah J, Mouzat K, Antar C, Gordon PH, Veyrat-Durebex C, Besson G, Andersen PM, Salachas F, Meininger V, Camu W, Pettmann B, Andres CR, Corcia P; French ALS Study Group.

Hum Mutat. 2013 Jul;34(7):953-60. doi: 10.1002/humu.22329. Epub 2013 May 28.

PMID:
23568759
31.

Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives.

Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE.

JAMA Neurol. 2013 Apr;70(4):476-80.

PMID:
23440294
32.

Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome?

Guennoc AM, Heuze-Vourc'h N, Gordon PH, Courty Y, Vourc'h P, Andres CR, Corcia P.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):476-8. doi: 10.3109/21678421.2013.764567. Epub 2013 Jan 28. No abstract available.

PMID:
23356346
33.

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.

Corcia P, Gordon PH.

Ther Clin Risk Manag. 2012;8:359-66. doi: 10.2147/TCRM.S21981. Epub 2012 Aug 27.

34.

Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.

Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat PF, Bruneteau G, Elbaz A, Meininger V.

Neurodegener Dis. 2013;12(2):81-90. doi: 10.1159/000341316. Epub 2012 Aug 21.

PMID:
22922503
35.

Parkinson's disease among American Indians and Alaska natives: a nationwide prevalence study.

Gordon PH, Mehal JM, Holman RC, Rowland AS, Cheek JE.

Mov Disord. 2012 Sep 15;27(11):1456-9. doi: 10.1002/mds.25153. Epub 2012 Aug 14.

PMID:
22893192
36.

Amyotrophic lateral sclerosis: a hormonal condition?

Blasco H, Guennoc AM, Veyrat-Durebex C, Gordon PH, Andres CR, Camu W, Corcia P.

Amyotroph Lateral Scler. 2012 Oct;13(6):585-8. doi: 10.3109/17482968.2012.706303. Epub 2012 Aug 8. Review.

PMID:
22873563
37.

Improving survival in a large French ALS center cohort.

Gordon PH, Salachas F, Bruneteau G, Pradat PF, Lacomblez L, Gonzalez-Bermejo J, Morelot-Panzini C, Similowski T, Elbaz A, Meininger V.

J Neurol. 2012 Sep;259(9):1788-92. doi: 10.1007/s00415-011-6403-4. Epub 2012 Jan 19.

PMID:
22258480
38.

How can we improve clinical trials in amyotrophic lateral sclerosis?

Gordon PH, Meininger V.

Nat Rev Neurol. 2011 Sep 27;7(11):650-4. doi: 10.1038/nrneurol.2011.147. Review.

PMID:
21947135
39.

Absence of the OPTN mutation in a patient with ALS and familial primary open angle glaucoma.

Corcia P, Praline J, Guennoc AM, Thépault RA, Gordon PH, Blasco H, Andres CR, Vourc'h P.

J Neurol Sci. 2011 Oct 15;309(1-2):16-7. doi: 10.1016/j.jns.2011.07.044. Epub 2011 Aug 17.

PMID:
21851955
40.

Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A.

Eur J Epidemiol. 2011 Sep;26(9):729-37. doi: 10.1007/s10654-011-9595-0. Epub 2011 Jun 15.

PMID:
21674216
41.

The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance.

Gordon PH, Delgadillo D, Piquard A, Bruneteau G, Pradat PF, Salachas F, Payan C, Meininger V, Lacomblez L.

Amyotroph Lateral Scler. 2011 Sep;12(5):372-8. doi: 10.3109/17482968.2011.580847. Epub 2011 May 17.

PMID:
21585273
42.

Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance.

Di Fabio F, Lykoudis P, Gordon PH.

Semin Thromb Hemost. 2011 Apr;37(3):220-5. doi: 10.1055/s-0031-1273086. Epub 2011 Mar 31. Review.

PMID:
21455856
43.

Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis.

Blasco H, Vourc'h P, Nadjar Y, Ribourtout B, Gordon PH, Guettard YO, Camu W, Praline J, Meininger V, Andres CR, Corcia P; French ALS study group.

J Neurol Sci. 2011 Apr 15;303(1-2):124-7. doi: 10.1016/j.jns.2010.12.018. Epub 2011 Jan 26.

PMID:
21276595
44.

APOE ε4 allele is associated with an increased risk of bulbar-onset amyotrophic lateral sclerosis in men.

Praline J, Blasco H, Vourc'h P, Garrigue MA, Gordon PH, Camu W, Corcia P, Andres CR; French ALS Study Group.

Eur J Neurol. 2011 Aug;18(8):1046-52. doi: 10.1111/j.1468-1331.2010.03330.x. Epub 2011 Jan 20.

PMID:
21251163
45.

Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Gordon PH.

CNS Drugs. 2011 Jan;25(1):1-15. doi: 10.2165/11586000-000000000-00000. Review.

PMID:
21128691
46.

Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.

Limousin N, Blasco H, Corcia P, Gordon PH, De Toffol B, Andres C, Praline J.

J Neurol Sci. 2010 Oct 15;297(1-2):36-9. doi: 10.1016/j.jns.2010.06.028. Epub 2010 Jul 31.

PMID:
20673675
47.

Respiratory onset in an ALS family with L144F SOD1 mutation.

Corcia P, Petiot P, Stevic Z, Vourc'h P, Morales R, Gordon PH, Pageot N, Andres C, Camu W.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):747-9. doi: 10.1136/jnnp.2009.197558. Epub 2010 Jun 20.

PMID:
20562451
48.

Progression in ALS is not linear but is curvilinear.

Gordon PH, Cheng B, Salachas F, Pradat PF, Bruneteau G, Corcia P, Lacomblez L, Meininger V.

J Neurol. 2010 Oct;257(10):1713-7. doi: 10.1007/s00415-010-5609-1. Epub 2010 Jun 8.

PMID:
20532545
49.

Screening for colorectal carcinoma.

Gordon PH.

Curr Oncol. 2010 Apr;17(2):34-9.

50.

A prospective cohort study of neuropsychological test performance in ALS.

Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, Marder K, Stern Y, Mitsumoto H.

Amyotroph Lateral Scler. 2010 May 3;11(3):312-20. doi: 10.3109/17482961003622585.

PMID:
20225929

Supplemental Content

Loading ...
Support Center